Abstract
Despite continued control efforts, tuberculosis remains a leading cause of illness and death worldwide, with more cases today than at any previous time in history. Not only is there a global increase in the disease itself, there is a worrying rise in the number of cases resistant to the two principal antituberculosis drugs, isoniazid and rifampicin--so called multidrug resistance.
MeSH terms
-
Antitubercular Agents / therapeutic use
-
Drug Resistance, Bacterial
-
Global Health*
-
Humans
-
Isoniazid / therapeutic use
-
Rifampin / therapeutic use
-
Tuberculosis, Multidrug-Resistant / drug therapy
-
Tuberculosis, Multidrug-Resistant / economics
-
Tuberculosis, Multidrug-Resistant / epidemiology
-
Tuberculosis, Multidrug-Resistant / prevention & control*
Substances
-
Antitubercular Agents
-
Isoniazid
-
Rifampin